MD - CIK 0000893949
The table below shows Pediatrix Medical Group, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $240.79M | $238.44M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $227.54M |
| $231.40M |
| $263.36M |
| $248.95M |
| Operating income | $208.81M | -$68.71M | $7.32M | $172.69M | $202.92M | $98.13M |
| Income tax | $51.04M | -$2.27M | $12.05M | $18.81M | $27.24M | $16.73M |
| Net income | $165.39M | -$99.07M | -$60.41M | $66.33M | $130.96M | -$796.49M |
| EPS (diluted) | $1.94 | -$1.19 | -$0.73 | $0.79 | $1.53 | -$9.55 |